Nasdaq GlobeNewswire

Partners Justin Watts and Matthew Shade Bolster WilmerHale's IP Litigation Practice in London

Del

LONDON, June 27, 2017 (GLOBE NEWSWIRE) -- WilmerHale today announced that Justin Watts, PhD, and Matthew Shade, PhD, have joined the firm as partners in its London office, strengthening WilmerHale's position as a firm of choice for complex patent litigation in the United Kingdom and for clients seeking an effective global strategy for their intellectual property disputes.

Dr. Watts, a first-chair patent litigator with deep experience in international disputes including competition matters, and Dr. Shade, a skilled practitioner and former patent examiner in the European Patent Office, come to WilmerHale from a Magic Circle firm, where Dr. Watts was the head of the firm's UK IP litigation practice. Together they bring more than 30 years of combined practice, with experience in a wide range of technologies, including cell phones, pharmaceutical products, semiconductors and aero engines."

"Justin and Matthew are an impressive duo who will substantially strengthen our international patent litigation capabilities," said Susan Murley, co-managing partner of WilmerHale. "Their experience with high-stakes IP litigation work and ability to manage complex international patent disputes will benefit our life sciences and tech clients alike."

"The opportunity to join WilmerHale allows us to be a part of a firm that boasts the most esteemed IP litigation practice in the United States," said Dr. Watts. "Matthew and I are looking forward to joining the WilmerHale team and contributing our UK and EU expertise to extend the ways in which clients can rely upon WilmerHale for well-coordinated and comprehensive guidance in global patent litigation matters."

WilmerHale's IP Litigation Practice features a premier litigation team backed by the academic and industry experience of more than 100 lawyers and technology specialists with scientific or technical degrees. WilmerHale's lawyers have tried major cases in US federal district courts from coast to coast, before the US International Trade Commission, and in Germany and the United Kingdom. The firm's lawyers also regularly represent clients in patent appeals before the US Supreme Court and the Federal Circuit. Since the first year the title of IP Litigation Department of the Year was awarded in 2004, The American Lawyer has honored WilmerHale twice and a finalist six times in this biennial contest. 

Mark Selwyn, co-chair of WilmerHale's IP Litigation Practice, added, "It is with great pride that we welcome Justin and Matthew. They bring a superb track record of success and commitment to legal excellence, and they will further enhance our ability to offer clients the finest representation for their global IP litigation disputes." 

Biographical Information

Dr. Justin Watts

Justin Watts, a patent litigator, was most recently a partner in the IP and information technology practices of a Magic Circle firm, where he was the head of the firm's UK IP litigation practice. Dr. Watts has handled complex, multinational disputes, often involving the intersection of antitrust and intellectual property. He has appeared before UK courts and high courts of Northern Ireland and Singapore, and has coordinated international patent litigation in the US, Germany and the Netherlands. His clients span a range of industries from pharmaceutical and medical device to technology, media and communications.

Dr. Watts is a highly regarded practitioner, earning consistent recognition by industry publications such as Chambers UK and The Legal 500 UK, by which he has been cited as "one of the best and most strategic litigators in the field."

Before his legal career began in 1994, Dr. Watts worked in satellite communications engineering. He earned his BA in electrical sciences and his PhD in optoelectronics from the University of Cambridge, and his diploma in IP law and practice, with commendation, from the University of Bristol.

Dr. Matthew Shade

Matthew Shade was most recently a patent litigator at a Magic Circle firm, where he was a member of the firm's intellectual property and information technology practices since 2007. His work focuses on complex multijurisdictional patent cases, and he often deals with the interface of intellectual property and antitrust law. Dr. Shade has practiced before the English courts and the European Patent Office. His clients span industries from pharmaceuticals and medical devices to consumer electronics.

Previously, Dr. Shade managed the patent department of a high-tech spin-out from Cambridge University and he was a patent examiner at the European Patent Office. He earned his BS, with honors, from the University of Manchester, and his PhD in chemistry from the University of Oxford. He is a registered solicitor in England and Wales and a European patent attorney.

About Wilmer Cutler Pickering Hale and Dorr LLP

WilmerHale provides legal representation across a comprehensive range of practice areas that are critical to the success of its clients. The law firm's leading Intellectual Property, Litigation/Controversy, Regulatory and Government Affairs, Securities and Transactional Departments participate in some of the highest-profile legal and policy matters. With a staunch commitment to public service, the firm is renowned as a leader in pro bono representation. WilmerHale is 1,000 lawyers strong with 12 offices in the United States, Europe and Asia. For more information, please visit www.wilmerhale.com.

Lauren C. Bishop
WilmerHale
lauren.bishop@wilmerhale.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: WilmerHale via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

CNP Assurances: Pre Stabilisation Notice20.6.2018 13:41Pressemelding

PARIS, June 20, 2018 (GLOBE NEWSWIRE) -- EURONEXT PARIS: CNP 20 th June 2018 CNP Assurances Stabilisation Notice HSBC (contact: 'Syndicate desk'; telephone: +44 207 992 8066) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities The securities: Issuer: CNP Assurances Guarantor (if any): Aggregate nominal amount: EUR Bmk Description: EUR Perpetual Fixed Rate Resettable Restricted Tier 1 Notes Offer price: TBC Other offer terms: Stabilisation: Stabilising Manager(s): Credit Suisse / HSBC (B&D) / Morgan Stanley / Natixis / SG CIB / Unicredit Stabilisation period expected to start on: 20th June 2018 Stabilisation period expected to end no later than: 20th July 2018 Existence, maximum size & conditions of use of over-allotment facility: 5% of the aggregate nominal amount Stabilisation Venue(s) Over the counter (OTC) In connection with the offer of the above securities, the Stabilisation Manager(s)

Delta Air Lines Becomes Launch Operator of ATMOSPHÈRE Cabin with New Order for 20 Bombardier CRJ90020.6.2018 13:00Pressemelding

MONTRÉAL, June 20, 2018 (GLOBE NEWSWIRE) -- Bombardier Commercial Aircraft announced today that Delta Air Lines, Inc. of Atlanta, Georgia (Delta Air Lines) has signed a firm purchase agreement for 20 CRJ900 aircraft - becoming the launch operator of the new ATMOSPHÈRE cabin for CRJ Series regional jets. Based on the list price for the CRJ900 aircraft, the firm order is valued at approximately US$961 million. "We are thrilled that Delta continues to select the CRJ Series as the airline looks into the future growth of its regional operations," said Fred Cromer, president, Bombardier Commercial Aircraft. "Together with Delta, we have driven the development of regional aviation in the U.S., and we are looking forward to further enhancing regional air travel with the launch of the new ATMOSPHÈRE cabin with our long-standing and esteemed customer." The new CRJ900 aircraft with ATMOSPHÈRE cabin will fly under the Delta Connection brand in a comfortable two-class regional jet configuration wit

Bombardier's Chinese Joint Venture Wins Contract to Provide an INNOVIA Automated People Mover System to Shenzhen Airport20.6.2018 11:52Pressemelding

Bombardier Transportation / Bombardier's Chinese Joint Venture Wins Contract to Provide an INNOVIA Automated People Mover System to Shenzhen Airport . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. With this latest joint venture contract, Bombardier's automated people mover systems will be in service in China's five largest urban centers New generation of reliable and ecofriendly INNOVIA APMs to help Shenzhen airport meet growing passenger numbers BERLIN, June 20, 2018 (GLOBE NEWSWIRE) -- Note to editors: To view the photo associated with this press release, please visit the following link: http://www.globenewswire.com/NewsRoom/AttachmentNg/3eb2c427-92ce-4524-bf1a-8cf64b48ca9f Rail technology leader Bombardier Transportation announced today that its Chinese joint venture, CRRC Puzhen Bombardier Transportation Systems Limited (PBTS), has been awarded a contract from Shenzhen Airport Co. Ltd to provide a BOM

SD-WAN Provider Aryaka Within 1% of Surpassing VMware for SD-WAN Market Leadership, According to Latest IHS Markit Report20.6.2018 10:00Pressemelding

SAN MATEO, Calif., June 20, 2018 (GLOBE NEWSWIRE) -- Aryaka® announced today it has been named the largest pure play SD-WAN provider in Q1 2018 and is now within 1% of surpassing VMware for overall leadership in terms of market share and revenues, according to the latest industry report from IHS Markit. In addition to closing the gap on VMware, Aryaka is now 6% ahead of Cisco (post-Viptela acquisition) in the SD-WAN space. IHS Markit's most recent report shows Aryaka's share of the SD-WAN market reached 18% in Q1 2018, which is an increase from the previous quarter. "Aryaka's SD-WAN as-a-Service is a game-changer and enabler for global enterprises embarking on a digital transformation journey," said Gary Sevounts, Chief Marketing Officer at Aryaka. "Our growth and dominant market position are a direct result of our unique ability to enhance cloud/SaaS and on-premises application performance for globally distributed businesses. With a continued focus on application delivery, performance

Standard Lithium Provides Updates on Fully Funded Resource Assessments Program Underway20.6.2018 09:00Pressemelding

VANCOUVER, British Columbia, June 20, 2018 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. ("Standard Lithium" or the "Company") (TSXV:SLL) (FRA:S5L) is pleased to provide the following updates on the Company's fully funded resource assessment programs underway at its two brownfield lithium brine project locations. In Arkansas, the Company has begun sampling at all current, active, and permitted brine production wells from the 150,000+ acres of brine leases recently announced by the Company on May 9th, 2018 (link to news release here). The Company has also received total brine production data from the Arkansas Oil and Gas Commission (the "AOGC") for the last six years of production. The Company will continue sampling brine from these active production wells at regular intervals over the next one to two months. Analyses from this sampling program, combined with production volume data from the AOGC and extensive geophysical data the Company has received, will be used to assist in completing a

ERYTECH to Present at JMP Securities Life Science Conference20.6.2018 07:30Pressemelding

LYON, France, June 20, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq:ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that Chief Executive Officer, Gil Beyen, will present at the JMP Securities Life Science Conference, June 20, 2018 at The St. Regis, New York, in New York City. Conference Details: Conference: JMP Securities Life Science Conference Date: June 20, 2018 Presentation Time: 9:00 AM EDT / 3:00 CET About ERYTECH and eryaspase (GRASPA®): www.erytech.com Founded in Lyon, France in 2004, ERYTECH is a clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases. Leveraging its proprietary ERYCAPS platform, which uses a novel technology to encapsulate therapeutic drug substances inside red blood cells, ERYTECH has developed a pipeline of product candidates targeting markets with high u

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom